Convection-enhanced delivery for the treatment of brain tumors.
about
Overview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial FluidOncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapyEph receptors as therapeutic targets in glioblastomaEphs and Ephrins in malignant gliomasPhotothermal therapy of glioblastoma multiforme using multiwalled carbon nanotubes optimized for diffusion in extracellular spacePre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma ModelsMRI-based computational model of heterogeneous tracer transport following local infusion into a mouse hind limb tumorMR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound.Agile delivery of protein therapeutics to CNSHerpesvirus vectors for therapy of brain tumors.Migration capacity of human umbilical cord mesenchymal stem cells towards glioma in vivoExperimental approaches for the treatment of malignant gliomas.Canine spontaneous glioma: a translational model system for convection-enhanced deliverySingle compartment drug delivery.Image-guided convection-enhanced delivery into agarose gel models of the brainFormulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?Intracranial microcapsule chemotherapy delivery for the localized treatment of rodent metastatic breast adenocarcinoma in the brain.Novel central nervous system drug delivery systems.Maintaining therapeutic activity in the operating room: compatibility of a gamma-retroviral replicating vector with clinical materials and biofluids.Overcoming the challenges in the effective delivery of chemotherapies to CNS solid tumors.IL-13Rα2-Targeted Therapy Escapees: Biologic and Therapeutic Implications.Rhenium-186 liposomes as convection-enhanced nanoparticle brachytherapy for treatment of glioblastoma.Formation of droplet networks that function in aqueous environments.Distinct roles for fibroblast growth factor signaling in cerebellar development and medulloblastoma.Voxelized Model of Brain Infusion That Accounts for Small Feature Fissures: Comparison With Magnetic Resonance Tracer StudiesSelective anti-tumor activity of the novel fluoropyrimidine polymer F10 towards G48a orthotopic GBM tumors.Simultaneous targeting of Eph receptors in glioblastomaRe-Examining the Need for Tissue Diagnosis in Pediatric Diffuse Intrinsic Pontine Gliomas: A Review.Towards tailored therapy of glioblastoma multiforme.Frameless stereotactic targeting devices: technical features, targeting errors and clinical results.Overcoming the blood-brain barrier in chemotherapy treatment of pediatric brain tumors.FANCD2 re-expression is associated with glioma grade and chemical inhibition of the Fanconi Anaemia pathway sensitises gliomas to chemotherapeutic agents.Convection-Enhanced Delivery.Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery.Glutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood-brain barrier in rats.A novel ligand delivery system to non-invasively visualize and therapeutically exploit the IL13Rα2 tumor-restricted biomarker.The Microvascular Gap Junction Channel: A Route to Deliver MicroRNAs for Neurological Disease TreatmentNovel Molecular Multilevel Targeted Antitumor AgentsComparative analysis of lentiviral vectors and modular protein nanovectors for traumatic brain injury gene therapy.Targeting Malignant Brain Tumors with Antibodies.
P2860
Q26799981-99864A98-6823-4CD4-986B-DEEA17B13039Q26998111-0C669D63-CA89-4DE2-B921-8C5EC96BD334Q27000196-A934E3BA-8211-4D5A-8718-4391540B5E44Q27015780-7C785451-D1D0-44D0-821A-11619D8D2069Q28392605-3C52CACC-FA13-4015-80C1-858B3625792EQ28468398-12F6C4C4-C7AA-4460-A162-52BF876E6997Q28540719-20DED867-5EFC-41E9-A5F3-9362F03A812AQ30252977-2189A67A-E1EA-4E71-8DD0-27B390E45CD1Q34079647-854FBC19-1B5C-4367-9305-1CBA3E9730E6Q34091990-DC966796-4262-402E-A64B-54A818C506C0Q34095283-585C46BE-6C27-4816-A51A-A3D1A088C60BQ34127138-F58075A4-5A78-4DCC-AAAF-905E815E9716Q34133134-42674EDA-A9C8-46C5-900C-ED2527BC288AQ34263907-82BE9BED-D522-4F75-B3F1-C895957FF444Q34292447-5149DE19-9DF0-49DE-A234-B26F83AEB4FCQ34383339-AA93F847-68B1-4E13-B1E5-9F9FA9BE5A83Q34525981-A1FA013E-E1B9-46AB-B991-1A866E8F82B7Q35064473-A474A5E6-21B3-45DC-8D49-BA26AA2EB64EQ35184172-F514C1CA-7D17-43A2-ADBA-7DA88BAFA2FEQ35602796-A6B11C96-5CB0-43C2-8A7E-266D37F57511Q35626536-B86E94CF-5371-415F-A5C9-8201340C7F47Q35845261-CE9153AF-61EE-4045-86AD-D21A3D744E0CQ36077599-37305692-57FB-4276-8312-84BBB68213EEQ37256791-14EA8FAB-89C4-457F-AD6E-E7A058924129Q37401832-AA4873F7-4ACE-407D-A578-ED83165AC125Q37526280-0CD924F2-E174-40F8-9AB9-88D1B7DE50EDQ37644953-9B6EB481-64EE-4164-9191-200222DFA224Q37668034-11DDFFEA-D853-4620-9A4F-3866149A05AAQ37908815-869E4AC8-8D59-44F6-89B7-D1A8D680E739Q37955144-E8667B30-106C-4F50-8F12-0C58A214559FQ38133407-2BFB2158-A5E7-4EB0-853C-A3F15E2DCF94Q38390733-6F264D33-D950-4943-8079-BF462B9DA4FFQ38744447-6951F5B5-EF30-49CA-9BA2-9BA419B0A323Q38761724-A8495E4C-2970-4196-B1C8-3638AFC2A964Q39024233-F30D94F6-1D2F-420B-9A22-3FB0AB562B66Q39284797-BC0C3D6C-93C0-44C3-B3C4-3723FE19DE8EQ41243197-812A4059-AAD9-45D5-930F-E8AE231286A1Q41429679-17173778-D559-42C4-9DB2-C3D8EE8E4490Q41922961-26EC2B03-C6EE-4053-8057-3CADCE92CDB5Q42267793-A67F03B2-EAE8-49DC-B7CC-4339CA5F2A0B
P2860
Convection-enhanced delivery for the treatment of brain tumors.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Convection-enhanced delivery for the treatment of brain tumors.
@en
type
label
Convection-enhanced delivery for the treatment of brain tumors.
@en
prefLabel
Convection-enhanced delivery for the treatment of brain tumors.
@en
P2860
P356
P1476
Convection-enhanced delivery for the treatment of brain tumors.
@en
P2093
Stephen B Tatter
Waldemar Debinski
P2860
P304
P356
10.1586/ERN.09.99
P577
2009-10-01T00:00:00Z